CAPTRUST FINANCIAL ADVISORS - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 274 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$274,027
-22.2%
10,244
-0.8%
0.00%0.0%
Q1 2024$352,390
+37.5%
10,331
+16.6%
0.00%0.0%
Q4 2023$256,322
-10.3%
8,857
-14.5%
0.00%0.0%
Q3 2023$285,598
+26.1%
10,359
+65.7%
0.00%0.0%
Q1 2023$226,438
+5.1%
6,250
+3.5%
0.00%0.0%
Q4 2022$215,483
+7.7%
6,041
+2.1%
0.00%0.0%
Q3 2022$200,000
+115.1%
5,914
+84.6%
0.00%0.0%
Q2 2022$93,000
-3.1%
3,204
+7.4%
0.00%0.0%
Q1 2022$96,000
+190.9%
2,983
+163.3%
0.00%
Q4 2021$33,000
+17.9%
1,133
+8.7%
0.00%
Q3 2021$28,0000.0%1,042
+16.3%
0.00%
Q2 2021$28,000
+16.7%
896
-2.2%
0.00%
Q1 2021$24,000
+242.9%
916
+233.1%
0.00%
Q4 2020$7,000
+40.0%
275
+22.2%
0.00%
Q3 2020$5,000
+25.0%
225
+28.6%
0.00%
Q2 2020$4,0000.0%175
+34.6%
0.00%
Q3 2019$4,0000.0%1300.0%0.00%
Q2 2019$4,000
+300.0%
130
+766.7%
0.00%
Q2 2018$1,000150.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders